| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Biological evaluation of a multi-targeted small molecule inhibitor of tumor-induced angiogenesis. | Bioorg Med Chem Lett | 2006 | 0.95 |
| 2 | RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: synthesis and biological evaluation. | Bioorg Med Chem | 2005 | 0.94 |
| 3 | RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response. | Clin Cancer Res | 2013 | 0.84 |
| 4 | Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays. | Methods | 2012 | 0.79 |